Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study

por Kashiwagi, A, Kazuta, K, Goto, K, Yoshida, S, Ueyama, E, Utsuno, A
Publicado 2015

A randomized, double‐blind, placebo‐controlled study on long‐term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: res...

por Kashiwagi, A., Takahashi, H., Ishikawa, H., Yoshida, S., Kazuta, K., Utsuno, A., Ueyama, E.
Publicado 2015